Cohorts of rats were treated either with intravenous injections of α1-adrenoceptor antibody (AB) or with subcutaneous injections with α1-adrenoceptor peptide (PEP). Control animals received unspecific
Showing baseline median, median difference and interquartile range, Z-score, effect size, and significance, between baseline and 1- or 3-month follow-up timepoints, for participants’ self-reported sco